MDI Therapeutics
Advertisement
MDI Therapeutics is a pharmaceutical company based in Novi, MI, focused on developing innovative therapies for fibrosis and fibroproliferative diseases. Founded on key technologies from the University of Michigan, the company's lead program features a first-in-class oral inhibitor of plasminogen activator inhibitor PAI-1.
The company's scientific approach centers around the unique mechanisms of PAI-1, which plays a crucial role in regulating fibrinolysis and is implicated in chronic fibrotic diseases. MDI Therapeutics aims to address significant unmet medical needs as no approved drugs currently exist that directly inhibit PAI-1.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement